- Home
- PSHG vs BEAT Comparison
PSHG vs BEAT Comparison
Compare PSHG & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSHG | BEAT |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 23.9M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PSHG | BEAT |
|---|---|---|
| Price | $2.02 | $0.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $5.75 | $3.50 |
| AVG Volume (30 Days) | 103.0K | ★ 1.4M |
| Earning Date | 11-24-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $48.48 | N/A |
| Revenue Next Year | N/A | $1,197.12 |
| P/E Ratio | $1.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.48 | $0.36 |
| 52 Week High | $2.58 | $4.00 |
Technical Indicators
Market Signals| Indicator | PSHG | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 67.44 | 44.74 |
| Support Level | $1.63 | $0.38 |
| Resistance Level | $2.08 | $0.52 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 95.24 | 8.17 |
Price Performance
Historical ComparisonAbout PSHG Performance Shipping Inc.
Performance Shipping Inc is a shipping company. The company is a provider of shipping transportation services through the ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying container vessels and cargo along various shipping routes. It owns and operates Aframax and Suezmax tanker vessels.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.